331 related articles for article (PubMed ID: 34465825)
1. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
Kim H; Jung G; Kim JH; Byun SS; Hong SK
Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825
[TBL] [Abstract][Full Text] [Related]
2. Prostate Health Index (
Yan JQ; Huang D; Huang JY; Ruan XH; Lin XL; Fang ZJ; Gao Y; Jiang HW; Wu YS; Na R; Xu DF
Asian J Androl; 2022; 24(4):406-410. PubMed ID: 34782549
[TBL] [Abstract][Full Text] [Related]
3. Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3 + 4.
Kim H; Kim JK; Hong SK; Jeong CW; Ku JH; Kwak C
World J Urol; 2021 Jun; 39(6):1825-1830. PubMed ID: 32869150
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological factors associated with pathological upgrading from biopsy to prostatectomy in patients with ISUP grade group ≤2 prostate cancer.
Li X; Wang ZX; Zhu YP; Wang J; Yin YS; Zeng XY
Asian J Androl; 2022; 24(5):487-493. PubMed ID: 35170453
[TBL] [Abstract][Full Text] [Related]
5. Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.
Preisser F; Würnschimmel C; Pose RM; Heinze A; Steuber T; Michl U; Salomon G; Mandel P; Graefen M; Tilki D
Prostate; 2022 Feb; 82(2):254-259. PubMed ID: 34807461
[TBL] [Abstract][Full Text] [Related]
6. The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.
Helpap B; Ringli D; Tonhauser J; Poser I; Breul J; Gevensleben H; Seifert HH
Pathol Oncol Res; 2016 Apr; 22(2):349-56. PubMed ID: 26563277
[TBL] [Abstract][Full Text] [Related]
7. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer.
Guazzoni G; Lazzeri M; Nava L; Lughezzani G; Larcher A; Scattoni V; Gadda GM; Bini V; Cestari A; Buffi NM; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):455-66. PubMed ID: 22078333
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer.
Novak V; Vesely S; Luksanová H; Prusa R; Capoun O; Fiala V; Dolejsová O; Sedlacková H; Kucera R; Stejskal J; Zalesky M; Babjuk M
BMC Urol; 2020 Sep; 20(1):144. PubMed ID: 32894109
[TBL] [Abstract][Full Text] [Related]
9. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis.
Kesch C; Pantea V; Soeterik T; Marquis A; la Bombarda G; Morlacco A; Barletta F; Radtke JP; Darr C; Preisser F; Zattoni F; Marra G; van den Bergh RCN; Hadaschik B; Gandaglia G;
World J Urol; 2023 Feb; 41(2):427-434. PubMed ID: 36534151
[TBL] [Abstract][Full Text] [Related]
10. [Correlation analysis between prostate imaging report and data system score and pathological results of prostate cancer].
Zhu LY; Ding XF; Huang TB; Luan Y; Guo CH; Xu YZ; Wang F
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2663-2668. PubMed ID: 32921014
[No Abstract] [Full Text] [Related]
11. Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy.
Takeuchi N; Sakamoto S; Nishiyama A; Horikoshi T; Yamada Y; Iizuka J; Maimaiti M; Imamura Y; Kawamura K; Imamoto T; Komiya A; Ikehara Y; Akakura K; Ichikawa T
Clin Genitourin Cancer; 2018 Aug; 16(4):e817-e829. PubMed ID: 29576444
[TBL] [Abstract][Full Text] [Related]
12. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
Zhai L; Fan Y; Sun S; Wang H; Meng Y; Hu S; Wang X; Yu W; Jin J
Scand J Urol; 2018; 52(5-6):333-339. PubMed ID: 30895901
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
14. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
[TBL] [Abstract][Full Text] [Related]
15. Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling.
Luzzago S; Petralia G; Maresca D; Sabatini I; Cordima G; Brescia A; Verweij F; Garelli G; Mistretta FA; Cioffi A; Pricolo P; Alessi S; Ferro M; Matei DV; Renne G; de Cobelli O; Musi G
Urol Oncol; 2020 Dec; 38(12):929.e11-929.e19. PubMed ID: 32600928
[TBL] [Abstract][Full Text] [Related]
16. The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancer.
Esen B; Seymen H; Gurses B; Armutlu A; Koseoglu E; Tarim K; Ertoy Baydar D; Sarikaya AF; Canda AE; Balbay D; Kordan Y; Tilki D; Esen T; Demirkol MO
Prostate; 2024 Jan; 84(1):32-38. PubMed ID: 37661579
[TBL] [Abstract][Full Text] [Related]
17. Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsy.
De Luca S; Fiori C; Bollito E; Garrou D; Aimar R; Cattaneo G; De Cillis S; Manfredi M; Tota D; Federica M; Passera R; Porpiglia F
Minerva Urol Nefrol; 2020 Jun; 72(3):360-368. PubMed ID: 31619029
[TBL] [Abstract][Full Text] [Related]
18. The influence of prostate volume on pathological outcomes after radical prostatectomy: A single-center retrospective study.
Li Q; Yang Z; Wang Z; Sun J; Wen C; Yan H; Shen H; Wang W; Xu B; Xiang J; Teng X; Zhang C; Zheng X; Xie L
Medicine (Baltimore); 2023 Dec; 102(49):e36526. PubMed ID: 38065843
[TBL] [Abstract][Full Text] [Related]
19. Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen.
Eyrich NW; Wei JT; Niknafs YS; Siddiqui J; Ellimoottil C; Salami SS; Palapattu GS; Mehra R; Kunju LP; Tomlins SA; Chinnaiyan AM; Morgan TM; Tosoian JJ
Urol Oncol; 2022 Jan; 40(1):4.e1-4.e7. PubMed ID: 34753659
[TBL] [Abstract][Full Text] [Related]
20. Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring?
Van Praet C; Libbrecht L; D'Hondt F; Decaestecker K; Fonteyne V; Verschuere S; Rottey S; Praet M; De Visschere P; Lumen N;
Clin Genitourin Cancer; 2014 Jun; 12(3):160-6. PubMed ID: 24361055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
